HomeTNYA • NASDAQ
add
Tenaya Therapeutics Inc
Previous close
$1.36
Day range
$1.36 - $1.43
Year range
$0.36 - $4.01
Market cap
233.11M USD
Avg Volume
3.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.94M | -21.62% |
Net income | -20.28M | 20.91% |
Net profit margin | — | — |
Earnings per share | -0.12 | 60.00% |
EBITDA | -19.07M | 22.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.31M | -29.14% |
Total assets | 104.98M | -25.32% |
Total liabilities | 22.11M | -20.97% |
Total equity | 82.87M | — |
Shares outstanding | 166.51M | — |
Price to book | 2.67 | — |
Return on assets | -46.09% | — |
Return on capital | -50.71% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -20.28M | 20.91% |
Cash from operations | -15.60M | 21.36% |
Cash from investing | 8.86M | 129.44% |
Cash from financing | 380.00K | 1,125.81% |
Net change in cash | -6.36M | 87.26% |
Free cash flow | -8.57M | 23.42% |
About
Founded
2016
Headquarters
Website
Employees
97
